Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06516640
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-06-11
Brief Title:
Type 2 Continuous Glucose Monitoring Academy
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Randomized Control Trial Evaluating the Impact of Continuous Glucose Monitoring Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 2 Diabetes
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to evaluate the Impact of CGM Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 2 Diabetes
The first aim is to determine how feasible it is to adapt the CGM Academy curriculum to teach youth with T2D glucose management strategies
The second aim is to evaluate the effects of the CHLA CGM Academy metrics
The third aim is to explore the relationships between these metrics with diabetes distress diabetes family responsibilities and process metrics
Participants will join for a total of four weeks of education followed by a six-month clinical review They will have access to an online workbook and videos and will participate in virtual sessions with a diabetes educator who will cover glucose management strategies in-depth Participants will wear their preferred CGM system Dexcom or FreeStyle Libre provided via insurance and inserted at the baseline visit
The first aim is to determine how feasible it is to adapt the CGM Academy curriculum to teach youth with T2D glucose management strategies
The second aim is to evaluate the effects of the CHLA CGM Academy metrics
The third aim is to explore the relationships between these metrics with diabetes distress diabetes family responsibilities and process metrics
Participants will join for a total of four weeks of education followed by a six-month clinical review They will have access to an online workbook and videos and will participate in virtual sessions with a diabetes educator who will cover glucose management strategies in-depth Participants will wear their preferred CGM system Dexcom or FreeStyle Libre provided via insurance and inserted at the baseline visit
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None